Tumor necrosis factor is a survival and proliferation factor for human myeloma cells.

Abstract : Interleukin-6 (IL-6) is a major survival factor for malignant plasma cells. In patients with multiple myeloma (MM), cell lines whose survival and proliferation are dependent upon addition of exogenous IL-6 have been obtained. We show here that tumor necrosis factor-alpha (TNF-alpha) is also a survival factor for myeloma cell lines, although less potent than IL-6. The survival activity of TNF-alpha is not affected by anti-IL-6 or anti-gp130 monoclonal antibodies (mAbs). TNF-alpha also induces myeloma cells in the cell cycle and promotes the long-term growth of malignant plasma cell lines. As TNF-alpha is produced in patients with MM and associated with a poor prognosis, these results suggest that anti-TNF-alpha therapies could be useful in this disease.
Type de document :
Article dans une revue
European Cytokine Network, John Libbey Eurotext, 1999, 10 (1), pp.65-70
Liste complète des métadonnées

Littérature citée [3 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00142273
Contributeur : Monique Frei <>
Soumis le : mercredi 18 avril 2007 - 14:13:04
Dernière modification le : jeudi 5 juillet 2018 - 18:02:01
Document(s) archivé(s) le : mardi 6 avril 2010 - 23:38:45

Identifiants

  • HAL Id : inserm-00142273, version 1
  • PUBMED : 10210775

Collections

Citation

Michel Jourdan, Karin Tarte, Eric Legouffe, Jean Brochier, Jean-François Rossi, et al.. Tumor necrosis factor is a survival and proliferation factor for human myeloma cells.. European Cytokine Network, John Libbey Eurotext, 1999, 10 (1), pp.65-70. 〈inserm-00142273〉

Partager

Métriques

Consultations de la notice

247

Téléchargements de fichiers

481